Inhibitory effects of peroxisome proliferator-activated receptor γ on thyroid carcinoma cell growth

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4728-4735

  Martelli, Maria Luisa ^a   Iuliano, Rodolfo ^b   Le Pera, Ilaria ^c   Sama, Irene ^a   Monaco, Carmen ^b   Cammarota, Simona ^c   Kroll, Todd ^c   Chiariotti, Lorenzo ^a   Santoro, Massimo ^a   Fusco, Alfredo ^a,d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P27;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL GROWTH; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THYROID CARCINOMA;

APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; MUTATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; THIAZOLES; THIAZOLIDINEDIONES; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 18644367272     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-012054     Document Type: Article

References (41)

1. Auwerx J 1999 PPARγ, the ultimate thrifty gene. Diabetologia 42:1033-1049
2. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE 1996 Regulation of PPARγ gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561
3. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H 1998 Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47:98-103
4. Rieusset J, Andreelli D, Auboeuf D, Roques M, Vallier P, Riou JP, Auwerx J, Laville M, Vidal H 1999 Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor γ in human adipocytes. Diabetes 48:699-705
5. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM 1995 15-Deoxy-D12, 14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812
6. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W 1997 Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay. Mol Endocrinol 11:779-791
7. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM 1997 Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 94:4318-4323
8. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956
9. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer SD 1995 Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Expr 4:281-299
10. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK 1995 Structural organization of mouse peroxisome proliferator activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921-7925
11. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J 1997 Organization, promoter analysis and expression of the human PPARγ gene. J Biol Chem 272:18779-18789
12. Hansen JB, Petersen RK, Larsen BM, Bartkova J, Alsner J, Kristiansen K 1999 Activation of peroxisome proliferator activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 274:2386-2393
13. Altiok S, Xu M, Spiegelman B 1997 PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11:1987-1998
14. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM 1997 Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci USA 94:237-241
15. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP 1998 Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806-8811
16. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, Spiegelman BM 1998 Terminal differentiation of human breast cancer through PPARγ. Mol Cell 1:465-470
17. Brockman JA, Gupta RA, DuBois RN 1998 Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055
18. Kuboto T, Koshizuka K, Williamson IA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP 1998 Ligand for peroxisome proliferator activated receptor γ (troglitazone) has potent anti-tumor effects against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344-3352
19. Sarraf P, Mueller E, Jones D, King FJ, De Angelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM 1998 Differentiation and reversal of malignant changes in colon cancer through PPAR gamma. Nat Med 4:1046-1052
20. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapel A, Spiegelman BM, Eng C 1999 Loss-of-function mutations in PPARγ associated with human colon cancer. Mol Cell 3:799-804
21. Lefebvre A, Chen I, Desreumaux P, Najib J, Fruchart JC, Geboes K, Briggs M, Heyman R, Auwerx J 1998 Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4:1053-1057
22. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX-8-PPARγ1 fusion in oncogene human thyroid carcinoma. Science 289:1357
23. Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T 2001 Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 86:2170-2177
24. Baldassarre G, Belletti B, Bruni P, Boccia A, Trapasso F, Pentimalli F, Barone MV, Chiappetta G, Vento MT, Spiezia S, Fusco A, Viglietto G 1999 Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest 104:865-874
25. Scala S, Bruni P, Lo Muzio L, Mignogna M, Viglietto G, Fusco A 1998 Novel mutation of the PTEN gene in an Italian Cowden's disease kindred. Int J Oncol 13:665-668
26. Sambrook J, Fritsh E, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press
27. Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y 2000 Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human pancreatic carcinoma cells. Cancer Res 60:5558-5564
28. Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MAK, Fukuda R, Nagasue N, Kinoshita Y 2000 Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists. Br J Cancer 83:1394-1400
29. Eibl G, Wente MN, Reber HA, Hines OJ 2001 Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cells apoptosis. Biochem Biophys Res Commun 287:522-529
30. Asou H, Verbeek W, Williamson E, Elstner E, Kubota T, Kamada N, Koeffler HP 1999 Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferation activated receptor gamma and retinoids. Int J Oncol 15:1027-1031
31. Bishop-Bailey D, Hla T 1999 Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) gamma ligand 15-deoxy-Delta12, 14-prostaglandin J2. J Biol Chem 274:17042-17048
32. Brockman JA, Gupta RA, Dubois RN 1998 Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055
33. Clay CE, Namen AW, Alsumi G, Willingham MC, Higl KP, Kute TE, Trumboli AJ, Footch AN, Dawson PA, Chillon FH 1999 Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 20:1905-1911
34. Hirase N, Yanase T, Mu Y, Muta K, Umemura T, Takayanagi R, Nawata H 1999 Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60. Oncology 57(Suppl 2):17-26
35. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, Mastuzuwa T 1999 Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancers. Jpn J Cancer Res 90:75-80
36. Sugimura A, Kiriyama Y, Nochi H, Tsuchiya H, Tamoto K, Sakurada Y, Ui M, Tokumitsu Y 1999 Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor. Biochem Biophys Res Commun 261:833-837
37. Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y 1999 Activation of PPARγ inhibits cell growth and apoptosis in human gastric cancer cells. FEBS Lett 455:135-139
38. Hupfeld CJ, Weiss RH 2001 TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27. Am J Physiol Endocrinol Metab 281:207-216
39. Keelan JA, Sato TA, Marvin KW, Lander J, Gilmour RS, Mitchell MD 1999 15-Deoxy-Delta (12, 14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun 262:579-585
40. Demetri GD, Fletcher CDM, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM, Singer S 1999 Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor γ ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96:3951-3956
41. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, Kantoff PW 2000 Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer. Proc Natl Acad Sci USA 97:10990-10995